<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: breast cancer cells</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Red wine ingredient resveratrol stops breast cancer growth</title>
   	 <description>Cheers! A new research report appearing in the October 2011 issue of The FASEB Journal shows that resveratrol, the &quot;healthy&quot; ingredient in red wine, stops breast cancer cells from growing by blocking the growth effects of estrogen. This discovery, made by a team of American and Italian scientists, suggests for the first time that resveratrol is able to counteract the malignant progression since it inhibits the proliferation of hormone resistant breast cancer cells. This has important implications for the treatment of women with breast cancer whose tumors eventually develop resistance to hormonal therapy.</description>
     <link>http://medicalxpress.com/news/2011-09-red-wine-ingredient-resveratrol-breast.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 29 Sep 2011 10:17:17 EST</pubDate>
	 <guid isPermaLink="false">news236510225</guid>
	 
</item>
<item>
     <title>Protein 'switches' could turn cancer cells into tiny chemotherapy factories</title>
   	 <description>Johns Hopkins researchers have devised a protein &quot;switch&quot; that instructs cancer cells to produce their own anti-cancer medication.</description>
     <link>http://medicalxpress.com/news/2011-09-protein-cancer-cells-tiny-chemotherapy.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 23 Sep 2011 11:47:56 EST</pubDate>
	 <guid isPermaLink="false">news235997150</guid>
	 
</item>
<item>
     <title>Virus kills breast cancer cells in laboratory</title>
   	 <description>A nondisease-causing virus kills human breast cancer cells in the laboratory, creating opportunities for potential new cancer therapies, according to Penn State College of Medicine researchers who tested the virus on three different breast cancer types that represent the multiple stages of breast cancer development.</description>
     <link>http://medicalxpress.com/news/2011-09-virus-breast-cancer-cells-laboratory.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 22 Sep 2011 11:31:52 EST</pubDate>
	 <guid isPermaLink="false">news235909833</guid>
	 
</item>
<item>
     <title>Finding pathways to cancer progression may lead to identification of targeted therapies</title>
   	 <description>Researchers are working to discover how genes interact with each other to lead to cancer progression. This research is expected to lead the way toward the discovery of new targeted therapies against breast cancer, according to a study presented at the Second AACR International Conference on Frontiers in Basic Cancer Research, held here Sept. 14-18, 2011.</description>
     <link>http://medicalxpress.com/news/2011-09-pathways-cancer-identification-therapies.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 15 Sep 2011 14:10:42 EST</pubDate>
	 <guid isPermaLink="false">news235314614</guid>
	 
</item>
<item>
     <title>New protein may suppress breast cancer growth</title>
   	 <description>Research led by Dr. Suresh Alahari, the Fred Brazda Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans and its Stanley S. Scott Cancer Center, has found that a protein discovered by his laboratory can inhibit the growth of breast cancer cells. The research will be published September 14, 2011 online in the Journal of the National Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2011-09-protein-suppress-breast-cancer-growth.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 14 Sep 2011 16:30:53 EST</pubDate>
	 <guid isPermaLink="false">news235236613</guid>
	 
</item>
<item>
     <title>Gene therapy kills breast cancer stem cells, boosts chemotherapy</title>
   	 <description>Gene therapy delivered directly to a particularly stubborn type of breast cancer cell causes the cells to self-destruct, lowers chance of recurrence and helps increase the effectiveness of some types of chemotherapy, researchers at The University of Texas MD Anderson Cancer Center reported in the Sept. 13 edition of Cancer Cell.</description>
     <link>http://medicalxpress.com/news/2011-09-gene-therapy-breast-cancer-stem.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 12 Sep 2011 12:24:55 EST</pubDate>
	 <guid isPermaLink="false">news235049043</guid>
	 
</item>
<item>
     <title>Researchers overcome barrier to cancer immunotherapy</title>
   	 <description>(Medical Xpress) -- In lab studies, researchers at Virginia Commonwealth University Massey Cancer Center have effectively reprogrammed cells of the innate and adaptive immune system to overcome a key cancer defense mechanism and develop long-lasting memory to reject breast cancer cells and guard against tumor relapse.</description>
     <link>http://medicalxpress.com/news/2011-09-barrier-cancer-immunotherapy.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 02 Sep 2011 09:26:40 EST</pubDate>
	 <guid isPermaLink="false">news234174367</guid>
	 
</item>
<item>
     <title>Research aims to starve breast cancer cells</title>
   	 <description>The most common breast cancer uses the most efficient, powerful food delivery system known in human cells and blocking that system kills it, researchers report.</description>
     <link>http://medicalxpress.com/news/2011-08-aims-starve-breast-cancer-cells.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 29 Aug 2011 11:33:36 EST</pubDate>
	 <guid isPermaLink="false">news233836392</guid>
	 
</item>
<item>
     <title>Researchers discover how some breast cancers alter their sensitivity to estrogen</title>
   	 <description>Using human breast cancer cells and the protein that causes fireflies to glow, a Johns Hopkins team has shed light on why some breast cancer cells become resistant to the anticancer effects of the drug tamoxifen. The key is a discovery of two genetic &quot;dimmer switches&quot; that apparently control how a breast cancer gene responds to the female hormone estrogen.</description>
     <link>http://medicalxpress.com/news/2011-07-breast-cancers-sensitivity-estrogen.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 27 Jul 2011 11:50:01 EST</pubDate>
	 <guid isPermaLink="false">news230984527</guid>
	 
</item>
<item>
     <title>Roadmap published for dynamic mapping of estrogen signaling in breast cancer</title>
   	 <description>The first roadmap to mathematical modeling of a powerful basic &quot;decision circuit&quot; in breast cancer has been developed and published in Nature Reviews Cancer.</description>
     <link>http://medicalxpress.com/news/2011-06-roadmap-published-dynamic-estrogen-breast.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 16 Jun 2011 11:01:37 EST</pubDate>
	 <guid isPermaLink="false">news227440875</guid>
	 
</item>
<item>
     <title>Signaling pathways point to vulnerability in breast cancer stem cells</title>
   	 <description>Whitehead Institute researchers have identified signals from breast epithelial cells that can induce those cells to transition to and maintain a mesenchymal and stem cell-like cell state that imbues both normal and cancer cells with a greater ability to migrate and self-renew. Interrupting these signals strips the cells of the migratory, invasive and self-renewal abilities used by cancer stem cells to seed new tumors.</description>
     <link>http://medicalxpress.com/news/2011-06-pathways-vulnerability-breast-cancer-stem.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 09 Jun 2011 13:14:15 EST</pubDate>
	 <guid isPermaLink="false">news226844025</guid>
	 
</item>
<item>
     <title>New clinical trial to test novel approach to treat triple-negative breast cancer</title>
   	 <description>A multicenter clinical trial led by a researcher at the University of Maryland Marlene and Stewart Greenebaum Cancer Center will evaluate a new approach to treat triple-negative breast cancer, an often-aggressive type of cancer that is more common among African-Americans and young women. The study will help researchers determine if an experimental drug, entinostat, can reprogram tumor cells to express a protein called an estrogen receptor to make them sensitive to hormone therapy.</description>
     <link>http://medicalxpress.com/news/2011-06-clinical-trial-approach-triple-negative-breast.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 02 Jun 2011 14:24:39 EST</pubDate>
	 <guid isPermaLink="false">news226243467</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/newclinicalt.jpg" width="90" height="90" />
</item>
<item>
     <title>Silencing a deadly conversation in breast cancer</title>
   	 <description>While it is already known that breast cancer cells create the conditions for their own survival by communicating their needs to the healthy cells that surround them, Australian researchers have identified a new way of turning off that cellular cross talk.</description>
     <link>http://medicalxpress.com/news/2011-06-silencing-deadly-conversation-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 02 Jun 2011 09:27:12 EST</pubDate>
	 <guid isPermaLink="false">news226225621</guid>
	 
</item>
<item>
     <title>Scientists identify overactive genes in aggressive breast cancers</title>
   	 <description>Scientists at Dana-Farber Cancer Institute have identified an overactive network of growth-spurring genes that drive stem-like breast cancer cells enriched in triple-negative breast tumors, a typically aggressive cancer that is highly resistant to current therapies.</description>
     <link>http://medicalxpress.com/news/2011-06-scientists-overactive-genes-aggressive-breast.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 01 Jun 2011 12:14:51 EST</pubDate>
	 <guid isPermaLink="false">news226149269</guid>
	 
</item>
<item>
     <title>Enzyme may drive breast cancer growth</title>
   	 <description>A recently discovered enzyme drives the production of a potent form of estrogen in human breast cancer tissue, researchers from the University of Illinois at Chicago College of Medicine have found.</description>
     <link>http://medicalxpress.com/news/2011-05-enzyme-breast-cancer-growth.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 18 May 2011 16:14:24 EST</pubDate>
	 <guid isPermaLink="false">news224954046</guid>
	 
</item>
<item>
     <title>Cancer scientists discover new way breast cancer cells adapt to environmental stress</title>
   	 <description>An international research team led by Dr. Tak Mak, Director, The Campbell Family Institute for Breast Cancer Research at Princess Margaret Hospital (PMH), has discovered a new aspect of &quot;metabolic transformation&quot;, the process whereby tumour cells adapt and survive under conditions that would kill normal cells.</description>
     <link>http://medicalxpress.com/news/2011-05-cancer-scientists-breast-cells-environmental.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 15 May 2011 11:38:25 EST</pubDate>
	 <guid isPermaLink="false">news224678285</guid>
	 
</item>
<item>
     <title>Researcher maps far-reaching effects of estrogen signaling in breast cancer cells</title>
   	 <description>A UT Southwestern Medical Center researcher has identified the most comprehensive measurement to date of estrogen's effect on breast cancer cells, showing for the first time how immediate and extensive the effect is.</description>
     <link>http://medicalxpress.com/news/2011-05-far-reaching-effects-estrogen-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 05 May 2011 13:02:51 EST</pubDate>
	 <guid isPermaLink="false">news223819346</guid>
	 
</item>
<item>
     <title>Protein snapshots reveal clues to breast cancer outcomes</title>
   	 <description>Measuring the transfer of tiny amounts of energy from one protein to another on breast cancer cells has given scientists a detailed view of molecular interactions that could help predict how breast cancer patients will respond to particular therapies.</description>
     <link>http://medicalxpress.com/news/2011-05-protein-snapshots-reveal-clues-breast.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 05 May 2011 09:54:12 EST</pubDate>
	 <guid isPermaLink="false">news223807994</guid>
	 
</item>
<item>
     <title>Researchers discover protein that could help prevent the spread of cancer</title>
   	 <description>A protein capable of halting the spread of breast cancer cells could lead to a therapy for preventing or limiting the spread of the disease.</description>
     <link>http://medicalxpress.com/news/2011-05-protein-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 04 May 2011 15:48:34 EST</pubDate>
	 <guid isPermaLink="false">news223742896</guid>
	 
</item>
<item>
     <title>Resistance to anti-estrogen therapy in breast cancer due to natural cell response</title>
   	 <description>Most breast cancers are fueled by estrogen, and anti-estrogenic agents often work for a time to control the cancers. But many of these cancers become resistant to the drugs for reasons that are not understood, leaving patients with limited treatment options.</description>
     <link>http://medicalxpress.com/news/2011-04-resistance-anti-estrogen-therapy-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 04 Apr 2011 16:25:39 EST</pubDate>
	 <guid isPermaLink="false">news221153121</guid>
	 
</item>


</channel>
</rss>
